ANI Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$247,060
$227,813
$211,371
$197,122
Gross Profit
237,560
111,792
136,756
124,085
EBITDA
76,931
61,159
39,244
48,362
EBIT
54,318
38,527
15,963
25,471
Net Income
29,973
24,134
8,549
15,681
Net Change In Cash
247,060
227,813
211,371
197,122
Free Cash Flow
6,507
37,892
68,903
15,145
Cash
285,585
262,610
217,797
149,802
Basic Shares
21,228
21,093
20,308
20,046

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$883,366
$614,376
$486,816
$316,385
Gross Profit
364,166
305,303
177,600
EBITDA
207,268
63,121
106,603
25,040
EBIT
115,851
-4,610
46,812
-34,613
Net Income
78,337
-18,522
18,779
-47,896
Net Change In Cash
883,366
614,376
486,816
316,385
Cost of Revenue
-52,067
Free Cash Flow
185,225
47,064
100,448
-47,658
Cash
285,585
144,861
221,121
48,228
Basic Shares
21,228
19,318
18,194
16,260

Earnings Calls

QuarterEPS
2025-12-31
$2.33
2025-09-30
$2.04
2025-06-30
$0.36
2025-03-31
$0.69